Pharmacogenomics for infectious diseases in sub-Saharan Africa: Successes and opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacogenomics for infectious diseases in sub-Saharan Africa: Successes and opportunities

Published:2016-06 Issue: Volume:9 Page:3-5
ISSN:2212-0661
Container-title:Applied & Translational Genomics
language:en
Short-container-title:Applied & Translational Genomics

Author:

Chaudhry Mamoonah,Alessandrini Marco,Pepper Michael S.

Funder

Institute for Cellular and Molecular Medicine

University of Pretoria

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Molecular Biology,Biotechnology

Reference28 articles.

1. Incidence and predictors of adverse drug events in an African cohort of HIV-infected adults treated with efavirenz;Abah;GERMS,2015

2. Priority pharmacogenetics for the African continent: focus on CYP450;Alessandrini;Pharmacogenomics,2014

3. Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy;Apellániz-Ruiz;Clin. Cancer Res.,2015

4. A prospective study of adverse drug reactions to artemisinin-based combination therapy in a tertiary care hospital in India;Belhekar;Indian J Pharmacol.,2012

5. CYP2C8 polymorphism frequencies among malaria patients in Zanzibar;Cavaco;Eur. J. Clin. Pharmacol.,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics as part of recommended precision medicine for tuberculosis treatment in African populations: Could it be a reality?;Clinical and Translational Science;2023-06-08

2. Relevance of PM in Infectious and Non-communicable Chronic Diseases and Pandemics;Advancing Global Bioethics;2023

3. Precision Medicine in Control of Visceral Leishmaniasis Caused by L. donovani;Frontiers in Cellular and Infection Microbiology;2021-11-09

4. Pharmacogenetic considerations in the treatment of co-infections with HIV/AIDS, tuberculosis and malaria in Congolese populations of Central Africa;International Journal of Infectious Diseases;2021-03

5. Strategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir;Clinical Infectious Diseases;2020-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3